Total synthesis of remdesivir

TETRAHEDRON LETTERS(2022)

引用 5|浏览8
暂无评分
摘要
Remdesivir, the first drug approved by the FDA to treat COVID-19, is in high demand for patients infected with the SARS-CoV-2 virus. Herein, we report a facile approach minimizing the protecting group manipulations to afford remdesivir in good overall yield. (c) 2021 Elsevier Ltd. All rights reserved.
更多
查看译文
关键词
Remdesivir, Nucleotide, Nucleoside, COVID-19, RdRp
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要